<DOC>
	<DOCNO>NCT01295333</DOCNO>
	<brief_summary>The aim study compare randomize multicentric study early prophylactic introduction low dose LT4 ( 50 µg/d ) 15 day post-ablation ( experimental arm ) compare conventional approach base initiation LT4 soon first biological sign hypothyroidism . Two hundred patient Graves ' disease minimal ( eyelid retraction oculopalpebral asynergy ) non inflammatory ophthalmopathy ( clinical activity score 0 ) include study . The administrated iodine-131 activity adjust weight thyroid gland ( 20 MBq/g thyroid tissue ) . Patients evaluate 6 week , 3 month , 6 month 12 month post-ablation . The primary objective ass difference term quality life 3 month use specific questionnaire ( ThyPRO ) . Secondary objective compare quality life outcome different study visit ( use ThyPRO SF36 ) , fatigue ( MFIS ) depression ( Beck ) , autoimmune parameter ( sign ophthalmopathy , TSH receptor antibody assessment ) , efficacy medico-economic data .</brief_summary>
	<brief_title>Assessing Impact Early Systematic Hormonal Replacement After Radio-isotopic Ablation Graves'hyperthyroïdism Quality Life , Efficiency Tolerance</brief_title>
	<detailed_description />
	<mesh_term>Graves Disease</mesh_term>
	<criteria>Patient present hyperthyroïdie Basedowienne prove treatment iodine 131 . Patient without ophtalmopathie junior define score ophtalmopathie 0 1 score clinical activity 0 ( see secondary ) . Patient whose rate fT4 and\or fT3 low 1,5 time superior limit standard laboratory balance sheet ( assessment ) precede treatment iodine 131 ( 15j . Patient whose thyroïdien volume estimate echography lower 60 mL . Patient whose treatment antithyroïdiens synthesis interrupt least 5 day administration iodine 131 . 18 year old male feminine Patient . Patient present thyroïdien nodule suspect wickedness . Patient present disorder thyroïdiens know distort fixation I131 ( congestive heart failure class III IV , renal insufficiency ) . Patient receive intravenous way product hydrosoluble contrast radiography 4 week precede randomization , way intrathécale cholécystographie product contrast iodized three month precede randomization . Patient take medicine susceptible disrupt function thyroïdienne renal ( renal medicine , lithium , amiodarone , particular ) . Patient present contraindication Levothyroxine high dose : décompensée heart disorder , coronaropathie , shady unchecked rhythm . pregnant breastfeed Women , patient able child refuse follow reliable contraceptive method duration study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>